Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Louna-Eesti Haigla AS

Estonia Meegomae Village, 65526 Voru, Estonia

  • 1 trial recruiting
  • Urinary tract infection · Diabetic foot infection · Pyelonephritis acute
  • Adult patients

About Specializations

Louna-Eesti Haigla AS in Voru, Estonia specialises in clinical trials of conditions such as Urinary tract infection, Diabetic foot infection, Pyelonephritis acute, and other specialisations. This site conducts important research.

Main research areas of the site

Bacterial Infections and Mycoses

Louna‑Eesti Haigla AS is dedicated to advancing treatment for serious bacterial infections, with a particular focus on complicated urinary tract infection (cUTI) and acute pyelonephritis (AP). The centre evaluates both oral and intravenous antimicrobial options to enhance patient recovery.

  • Oral tebipenem versus IV imipenem‑cilastatin
  • Cefepime/nacubactam and aztreonam/nacubactam combinations
  • Assessment of overall clinical cure and microbiological eradication
  • Safety profiling of new antibiotic regimens

With two investigators overseeing two active trials, the site aims to improve therapeutic outcomes for adults hospitalized with cUTI or AP, contributing valuable data to the field of antimicrobial therapy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Meegomae Village65526 VoruEstonia
Open in maps ↗
Recruiting now
1 trial
Conditions studied
3

More sites in VoruEstonia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Diabetic foot infection

Recruiting
Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Micurx Pharmaceuticals Inc.

Urinary tract infection+1

Not recruiting
Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Meiji Seika Pharma Co. Ltd.

Urinary tract infection

Not recruiting
Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.

Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

Not recruiting
Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Aminocaproic Acid
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.